Abstract:Automated Sign Language Recognition for under-represented languages remains a largely unsolved problem. Central African Sign Language (CASL) exemplifies this gap: the only available bench-mark, CASL-W60, has a best reported accuracy of 69.93%, and we show that the common heuristic of fine-tuning high-resource models fails to close it. This failure stems from two compounding factors: the limited scale of available CASL data and the significant lexical and visual domain gap between CASL and large-scale corpora such as WLASL, which renders pre-trained representations largely uninformative. To address this, we propose TransSLR, a lightweight Temporal Transformer Encoder trained from scratch on 64-frame normalized pose sequences, with average pooling and a classification head. By operating on geometric keypoint representations rather than raw RGB, TransSLR achieves signer-independent generalization without relying on visual appearance. On the CASL-W60 benchmark, TransSLR establishes a new state-of-the-art accuracy of 80.39%, surpassing the prior best by +10.46%. Beyond accuracy, our encoder-only design significantly reduces computational overhead, making deployment feasible in resource-constrained environments. We conduct extensive experiments on the CASL-W60 benchmark, comparing against RGB-based and multimodal baselines, and demonstrate that TransSLR achieves state-of-the-art performance.
Abstract:Automated diagnosis from chest computed tomography (CT) scans faces two persistent challenges in clinical deployment: distribution shift across acquisition sites and performance disparity across demographic subgroups. We address both simultaneously across two complementary tasks: binary COVID-19 classification from multi-site CT volumes (Task 1) and four-class lung pathology recognition with gender-based fairness constraints (Task 2). Our framework combines a lightweight MobileViT-XXS slice encoder with a two-layer SliceTransformer aggregator for volumetric reasoning, and trains with a KL-regularised Group Distributionally Robust Optimisation (Group DRO) objective that adaptively upweights underperforming acquisition centres and demographic subgroups. Unlike standard Group DRO, the KL penalty prevents group weight collapse, providing a stable balance between worst-case protection and average performance. For Task 2, we define groups at the granularity of gender class, directly targeting severely underrepresented combinations such as female Squamous cell carcinoma. On Task 1, our best configuration achieves a challenge F1 of 0.835, surpassing the best published challenge entry by +5.9. On Task 2, Group DRO with α = 0.5 achieves a mean per-gender macro F1 of 0.815, outperforming the best challenge entry by +11.1 pp and improving Female Squamous F1 by +17.4 over the Fo- cal Loss baseline.